Patrick Schöffski
帕特里克·舍夫斯基
MD, PhD
Professor of Oncology and Head, Department of General Medical Oncology肿瘤学教授兼综合肿瘤内科主任
👥Biography 个人简介
International leader in sarcoma phase I–III trials and regorafenib development in soft tissue sarcoma. A key figure in European sarcoma research, has led multiple EORTC and investigator-initiated trials of novel agents in sarcoma, advancing eribulin and regorafenib in STS.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Regorafenib and Novel Agents in Sarcoma
Led the REGOSARC phase 2 trial demonstrating regorafenib activity across multiple STS subtypes and contributed to the clinical development of eribulin and other agents in advanced soft tissue sarcoma.
Representative Works 代表性著作
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet (2017)
Contributed to multi-tumor regorafenib data supporting its utility in sarcoma subtypes as defined by the REGOSARC trial.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 帕特里克·舍夫斯基 的研究动态
Follow Patrick Schöffski's research updates
留下邮箱，当我们发布与 Patrick Schöffski（KU Leuven / University Hospitals Leuven）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment